Observational study identifies individual CKM syndrome components affecting cardiovascular events, suggesting targeted prevention strategies.
Cardio-Kidney-Metabolic (CKM) syndrome represents a constellation of interconnected metabolic and renal abnormalities, including hypertension, diabetes, dyslipidemia, and chronic kidney disease (CKD), all of which contribute to increased cardiovascular disease (CVD) risk. While CKM syndrome has been proposed as a holistic framework for risk stratification, the relative impact of each individual component on major adverse cardiovascular events (MACEs) has not been well defined.
No takes yet. Share an insight, caveat, or question.
Yun et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: